Moleculin Biotech, Inc. (MBRX)

Prev Close 3.56
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.34 / 9.58
Exchange NASDAQ
Shares Outstanding 11.26B
Market Cap 33.54M
Div & Yield N.A. (N.A)

Latest News

Ligand Completes Acquisition Of Metabasis

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that it has completed the acquisition of Metabasis Therapeutics, Inc.

Ballard, QLT: Early Volume Plays

Several small-cap stocks were poised to move on above-average volume during Tuesday's session.

Midday Movers: Pump Up the Volume

Several small-cap stocks were moving on above-average volume during Thursday's session.

Tuesday's Late Winners & Losers

Capstone Turbine shares jumped on a big order.

Monday's Health Winners & Losers

Accentia climbs on SinuNase study results.

Stockpickr Lists: Keystone Auto Keyed Up

The stock rises on unusual volume as news of an acquisition emerges.

Tuesday's Health Winners & Losers

Cortex Pharma climbs on greenlight from the FDA for an Alzheimer's trial.

Drug Data Dents Metabasis

Shares slump on disappointing results for type 2 diabetes candidate CS-917.

Metabasis, Valeant Rise

They sign a deal with Schering-Plough.

Gilead Gains a Bit Too Much Respect

It boasts best-in-class drugs, but its bump from Tamiflu is temporary and its valuation implies risk.

Metabasis, Merck Reach R&D Pact

Both companies will offer drug candidates to the venture.

Health Stocks in Motion

Metabasis Therapeutics falls after halting two diabetes trials.